Substantially improving the survival rate of the world's deadliest cancers through early detection

Our purpose

Circular Vision 2.0 is an innovative initiative led by the University of Copenhagen, in partnership with its spinout company CARE-DNA IP, focused on advancing early cancer diagnostic technologies. Building upon the foundational work of Circular Vision 1.0, this project is supported by the European Innovation Councils (EIC) Transition Grant, facilitating the development and translation of cutting-edge solutions into clinical applications.